Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kieron Dunleavy

Showing results (61-70 of 130) with videos related to

Pageof 13
Sort By:
Current Opinion in Hematology|May 31, 2007
Angioimmunoblastic T cell lymphoma: pathobiological insights and clinical implicationsKieron Dunleavy, Wyndham H Wilson, Elaine S Jaffe
Leukemia & Lymphoma|June 20, 2007
The BCL-2 biomarker in the era of molecular diagnosis of diffuse large B-cell lymphomaKieron Dunleavy, Louis M Staudt, Wyndham H Wilson
American Journal of Hematology|September 7, 2022
Multiple myeloma with central nervous system relapse presenting as right pupil-sparing complete third nerve palsyAndrew Tiu, Jennifer Marks, Roaa Aljuaid, et al.
Leukemia & Lymphoma|June 18, 2019
Hybrid dosing of the cyclin-dependent kinase (CDK) inhibitor flavopiridol in relapsed/refractory mantle cell lymphoma and diffuse large B-cell lymphomaMilos D Miljkovic, Mark Roschewski, Kieron Dunleavy, et al.
Clinical Nuclear Medicine|December 23, 2003
F-18 fluorodeoxyglucose positron emission tomographic imaging in a patient with persistent hiccupsJohn D Nguyen, Kieron Dunleavy, Jorge A Carrasquillo, et al.
Cancer Biology & Therapy|March 11, 2015
Targeted PI3Kδ inhibition by the small molecule idelalisib as a novel therapy in indolent non-Hodgkin lymphomaTracy C Okoli, Cody J Peer, Kieron Dunleavy, et al.
Blood|December 19, 2015
Discordant bone marrow involvement in non-Hodgkin lymphomaJennifer Brudno, Tamar Tadmor, Stefania Pittaluga, et al.
Histopathology|November 15, 2024
Evolving molecular classification of aggressive B-cell lymphomaStefan K Alig, Björn Chapuy, Daisuke Ennishi, et al.
Leukemia & Lymphoma|July 28, 2010
The value of positron emission tomography in prognosis and response assessment in non-Hodgkin lymphomaKieron Dunleavy, George Mikhaeel, Laurie H Sehn, et al.
Blood|January 11, 2007
BCL-6 and rituximab in diffuse large B-cell lymphoma: where are we?Kieron Dunleavy, R Eric Davis, Ola Landgren, et al.
Pageof 13

Showing results (61-70 of 130) with videos related to

Sort By:
Pageof 13
Current Opinion in Hematology|May 31, 2007
Angioimmunoblastic T cell lymphoma: pathobiological insights and clinical implicationsKieron Dunleavy, Wyndham H Wilson, Elaine S Jaffe
Leukemia & Lymphoma|June 20, 2007
The BCL-2 biomarker in the era of molecular diagnosis of diffuse large B-cell lymphomaKieron Dunleavy, Louis M Staudt, Wyndham H Wilson
American Journal of Hematology|September 7, 2022
Multiple myeloma with central nervous system relapse presenting as right pupil-sparing complete third nerve palsyAndrew Tiu, Jennifer Marks, Roaa Aljuaid, et al.
Leukemia & Lymphoma|June 18, 2019
Hybrid dosing of the cyclin-dependent kinase (CDK) inhibitor flavopiridol in relapsed/refractory mantle cell lymphoma and diffuse large B-cell lymphomaMilos D Miljkovic, Mark Roschewski, Kieron Dunleavy, et al.
Clinical Nuclear Medicine|December 23, 2003
F-18 fluorodeoxyglucose positron emission tomographic imaging in a patient with persistent hiccupsJohn D Nguyen, Kieron Dunleavy, Jorge A Carrasquillo, et al.
Cancer Biology & Therapy|March 11, 2015
Targeted PI3Kδ inhibition by the small molecule idelalisib as a novel therapy in indolent non-Hodgkin lymphomaTracy C Okoli, Cody J Peer, Kieron Dunleavy, et al.
Blood|December 19, 2015
Discordant bone marrow involvement in non-Hodgkin lymphomaJennifer Brudno, Tamar Tadmor, Stefania Pittaluga, et al.
Histopathology|November 15, 2024
Evolving molecular classification of aggressive B-cell lymphomaStefan K Alig, Björn Chapuy, Daisuke Ennishi, et al.
Leukemia & Lymphoma|July 28, 2010
The value of positron emission tomography in prognosis and response assessment in non-Hodgkin lymphomaKieron Dunleavy, George Mikhaeel, Laurie H Sehn, et al.
Blood|January 11, 2007
BCL-6 and rituximab in diffuse large B-cell lymphoma: where are we?Kieron Dunleavy, R Eric Davis, Ola Landgren, et al.
Pageof 13